|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO00758900X |
| 003 |
DE-627 |
| 005 |
20230425173330.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210512s2022 xx |||||o 00| ||eng c |
| 035 |
|
|
|a (DE-627)WHO00758900X
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2020-005447-23-NL
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)75871
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 245 |
1 |
0 |
|a Intravenous imatinib for corona virus-related lung injury.
|b A randomised, double-blind, placebo-controlled study to investigate the safety and efficacy of intravenous imatinib mesilate (Impentri®) in subjects with Acute Respiratory Distress Syndrome induced by COVID-19. - Intravenous imatinib for COVID-19-related ARDS.
|
| 264 |
|
1 |
|c 2022
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 28-01-2021, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: COVID-19 related Acute Respiratory Distress Syndrome (ARDS) in mechanically-ventilated patients on the Intensive Care Unit. MedDRA version: 23.0Level: LLTClassification code 10084270Term: SARS-CoV-2 acute respiratory diseaseSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Phase: Phase 2
|
| 650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2022) vom: 04. Apr.
|
| 773 |
1 |
8 |
|g year:2022
|g day:04
|g month:04
|
| 856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2020-005447-23
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2022
|b 04
|c 04
|
Klinische Studie